Yoseph Shaaltiel, Executive VP, R&D at Protalix BioTherapeutics, Inc. (PLX), bought 15,100 shares at $3.15 ($47K) on 2007-12-05, disclosed to the SEC on 2007-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.05 | 2,100 | $6K | 13.5% |
| 2 | $3.15 | 9,700 | $31K | 64.5% |
| 3 | $3.16 | 3,300 | $10K | 22.0% |
| Total | $3.14 avg | 15,100 | $47K | 100% |
| Filing → |
| PLX | SELL | 2010-06-23 | $371K | — | Filing → |
| PLX | SELL | 2010-05-03 | $89K | — | Filing → |
| PLX | SELL | 2010-04-16 | $9K | — | Filing → |